Thu, June 7, 2018
Wed, June 6, 2018
Tue, June 5, 2018
Mon, June 4, 2018
Fri, June 1, 2018
Thu, May 31, 2018
Wed, May 30, 2018
Tue, May 29, 2018
Fri, May 25, 2018
Thu, May 24, 2018
Wed, May 23, 2018
Tue, May 22, 2018
Mon, May 21, 2018
Fri, May 18, 2018
Thu, May 17, 2018
Wed, May 16, 2018
Tue, May 15, 2018
Mon, May 14, 2018
Fri, May 11, 2018
Thu, May 10, 2018
Wed, May 9, 2018
Tue, May 8, 2018

Douglas Tsao Maintained (TEVA) at Hold with Increased Target to $20 on, May 24th, 2018


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-20-on-may-24th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Douglas Tsao of Barclays, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Increased Target from $13 to $20 on, May 24th, 2018.

Douglas has made no other calls on TEVA in the last 4 months.



There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 2 agree with Douglas's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Risinger of "Morgan Stanley" Maintained at Hold on, Monday, May 7th, 2018
  • Gregg Gilbert of "Deutsche Bank" Maintained at Hold with Decreased Target to $18 on, Friday, February 9th, 2018


These are the ratings of the 4 analyists that currently disagree with Douglas


  • Vamil Divan of "Credit Suisse" Maintained at Buy with Increased Target to $23 on, Monday, February 12th, 2018
  • Jason Gerberry of "B of A Securities" Maintained at Sell with Decreased Target to $16 on, Friday, February 9th, 2018
  • Ami Fadia of "Leerink Swann" Maintained at Sell with Decreased Target to $16 on, Friday, February 9th, 2018
  • David Amsellem of "Piper Sandler" Downgraded from Hold to Sell on, Friday, February 9th, 2018

Publication Contributing Sources